Triple-negative breast cancer (TNBC) is an aggressive malignancy characterized by the absence of an estrogen receptor (ER) and progesterone receptor (PR), as well as the lack of an overexpression of human epithelial cell growth factor receptor 2 (HER2) [1]. The gene discussed is ESR1; the disease is triple-negative breast carcinoma.